Portfolio – Q316

Portfolio Breakdown

My portfolio (at cost) of S’pore stocks for Q316 close,

% Holding

Stocks

Total

> 10%

KingsmenCreative

21.8%

  

M1

  

5-10%

Kep Infra Tr

22.6%

  

King Wan

  

  

SingPost

  

< 5%

Raffles Medical

24.0%

  

F & N

  

  

SGX

  

  

Genting Sing

  

  

Starhub

  

  

Frasers Com Tr

  

  

ARA Asset Mgt

  

Cash

  

31.6%

Note : Stocks are arranged in descending order of % holdings

 
Summary

The STI closed at 2869.47, -0.46% from end 2015. Using cost as a reference, my portfolio stats (vs 2015),

  • Size (Stocks Only) : -33.2% (Cost) / -33.5% (Market Value)
  • Portfolio Performance (Includes Cash) vs End-2015 Mkt Value : 6.06% (Unrealised) -5.28% (Realised) + 2.35% (Div) = +3.13%
  • Further Breakdown of Realised P&L : -6.37% (Stocks Bought before 2016) + 1.09% (Stocks Bought in 2016)

So, +3.13% vs -0.46% (STI), better than STI but the +ve was mainly due to accumulated dividends collected…. My cash position has increased as I have not been able to find many longer term stocks to invest in. It’ll likely stay that way till end-Dec to Jan when I start to take up bigger positions for the FY reporting season. Another reason for being less active is the kids’ exams season, followed by hols…

For Q3, I have added more KIT, with the intention for longer term yield. With Basslink back in operation, there ought to be better share price stability. I’m hoping they’ll sell Basslink as it’s a massive asset with massive debts. It’s also time for new acquisitions, likely funded by Rights & Debts. My SGX holding is also increased, more for the Double-xd bet. However, recent monthly figures don’t look good. The potential positive may come from their recent acquisition of the Baltic Exchange. I’m open to either selling or buying more, depending on the price. Having a Quarterly Payout Policy is a slight +ve for me. I have also added RafflesMed as a new stock to my portfolio. Altho’ it’s not cheap at PE closer to 40 and Yield slight above 1%, I have finally decided that I ought to buy and hold for longer term. Recent results have seen a much slower growth in EPS altho’ they do have quite a few projects on-going. I’ll likely accumulated more but I’m also inclined to do some trades.

Events to look out for in Q4, besides the Quarterly Reporting Season, are the 4th TELCO tender, where the process had started, with 3 interested parties (2 local and 1 Oz). The likelihood of a 4th TELCO is now very high and TELCO share prices had dropped back… again… I’ll likely continue to trade M1 & Starhub as the Yield are still attractive… if stuck… Singpost share prices had also recovered from it’s lows as the end-Oct deadline for Alibaba approaches… For me, the bigger risk is a potential dividend reduction. I’m more inclined to sell as and when BE is hit.

BREXIT, US Presidential Elections, FED Rate Hike,.. continues to be of interest…

 

Portfolio Changes (vs Q216)

  • New Additions : RafflesMed
  • Increases : SGX, KIT
  • Decreases : SingPost, Starhub
  • No Change : Kingsmen, King Wan, F&N, Genting, FCOT, M1, ARA
  • No More : A-HTrust, ComfortDelgro

  
 

Exchange Rates (for Q316)

  • IDR (Indonesia Rupiah) +2.35% : LMIR – Continued to increase, looking good
  • AUD (Australia $) +3.49% : AusNet, A-Htrust, Singtel – Turned positive, also for ’16
  • JPY (Japanese Yen) +2.84% : Continued Strength, +12.91% for the year, main safe haven in times of volatility

Leave a Reply